Harmen van Andel

801 total citations
11 papers, 630 citations indexed

About

Harmen van Andel is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Harmen van Andel has authored 11 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Hematology. Recurrent topics in Harmen van Andel's work include Peptidase Inhibition and Analysis (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Harmen van Andel is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Harmen van Andel collaborates with scholars based in Netherlands, Poland and Canada. Harmen van Andel's co-authors include Steven T. Pals, Marcel Spaargaren, Kinga A. Kocemba‐Pilarczyk, Hans Clevers, Marie José Kersten, Sander P.J. Joosten, Jurrit Zeilstra, Marc van de Wetering, Anton Berns and Cornelia Tölg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Harmen van Andel

11 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harmen van Andel Netherlands 10 433 210 129 98 92 11 630
Kym L. Stanley Australia 9 588 1.4× 310 1.5× 103 0.8× 123 1.3× 146 1.6× 10 893
Brinda Alagesan United States 5 354 0.8× 189 0.9× 78 0.6× 133 1.4× 90 1.0× 6 702
Patrycja Pawlikowska France 15 391 0.9× 177 0.8× 134 1.0× 137 1.4× 53 0.6× 24 682
Carol Wai Canada 4 646 1.5× 178 0.8× 174 1.3× 132 1.3× 43 0.5× 5 879
Patricia S. Hähnel Germany 10 297 0.7× 152 0.7× 112 0.9× 58 0.6× 38 0.4× 13 513
Ryan A. Denu United States 10 270 0.6× 155 0.7× 98 0.8× 93 0.9× 153 1.7× 24 502
Mathilde Romagnoli France 15 361 0.8× 226 1.1× 62 0.5× 161 1.6× 48 0.5× 24 584
Shiro Kataoka Japan 13 480 1.1× 219 1.0× 52 0.4× 103 1.1× 77 0.8× 27 717
Daniela Bossi Italy 12 484 1.1× 182 0.9× 172 1.3× 101 1.0× 25 0.3× 18 658
Jeannine Diesch Australia 15 591 1.4× 155 0.7× 99 0.8× 152 1.6× 35 0.4× 20 852

Countries citing papers authored by Harmen van Andel

Since Specialization
Citations

This map shows the geographic impact of Harmen van Andel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harmen van Andel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harmen van Andel more than expected).

Fields of papers citing papers by Harmen van Andel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harmen van Andel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harmen van Andel. The network helps show where Harmen van Andel may publish in the future.

Co-authorship network of co-authors of Harmen van Andel

This figure shows the co-authorship network connecting the top 25 collaborators of Harmen van Andel. A scholar is included among the top collaborators of Harmen van Andel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harmen van Andel. Harmen van Andel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Andel, Harmen van, Kinga A. Kocemba‐Pilarczyk, Marcel Spaargaren, & Steven T. Pals. (2019). Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options. Leukemia. 33(5). 1063–1075. 136 indexed citations
2.
Pals, Steven T., et al.. (2019). Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options. Clinical Lymphoma Myeloma & Leukemia. 19(10). e108–e108. 2 indexed citations
3.
Joosten, Sander P.J., Jurrit Zeilstra, Harmen van Andel, et al.. (2017). MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms. Gastroenterology. 153(4). 1040–1053.e4. 47 indexed citations
4.
Andel, Harmen van, Wim de Lau, Madelon M. Maurice, et al.. (2017). Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins. Blood. 131(9). 982–994. 63 indexed citations
5.
Stokman, Geurt, Lotte Kors, Elena Rampanelli, et al.. (2017). NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity. The Journal of Experimental Medicine. 214(8). 2405–2420. 91 indexed citations
6.
Maas, Chiel, Alexander M. de Bruin, Harmen van Andel, et al.. (2016). The DNA Damage Response Regulates RAG1/2 Expression in Pre–B Cells through ATM-FOXO1 Signaling. The Journal of Immunology. 197(7). 2918–2929. 26 indexed citations
7.
Andel, Harmen van, Kinga A. Kocemba‐Pilarczyk, Clemens Mellink, et al.. (2016). Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease. Oncogene. 36(15). 2105–2115. 41 indexed citations
8.
Andel, Harmen van, Sander P.J. Joosten, Kinga A. Kocemba‐Pilarczyk, et al.. (2016). Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins. Proceedings of the National Academy of Sciences. 114(2). 376–381. 40 indexed citations
9.
Kocemba‐Pilarczyk, Kinga A., Harmen van Andel, Karène Mahtouk, et al.. (2013). The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis. Leukemia. 27(8). 1729–1737. 31 indexed citations
10.
Zeilstra, Jurrit, Sander P.J. Joosten, Harmen van Andel, et al.. (2013). Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling. Oncogene. 33(5). 665–670. 112 indexed citations
11.
Kocemba‐Pilarczyk, Kinga A., Richard W.J. Groen, Harmen van Andel, et al.. (2012). Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma. PLoS ONE. 7(2). e30359–e30359. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026